Nextech Crossover
Startup rounds since 2014 with a Nextech Crossover investor on the board, and the firm's own fund filings.
Raises
16
since 2014
Unannounced
0
no announcement found, of those filed since 2025
Funds
1
fund filings under the firm's name
Rounds
- Stipple Bio, Inc.$65.1M
- Circle Pharma, Inc.$92.4M
- Circle Pharma, Inc.$66.3M
- Alterome Therapeutics, Inc.$63.8M
- Silverback Therapeutics, Inc.$85M
- Circle Pharma, Inc.$15M
- Silverback Therapeutics, Inc.$31.8M
- Revolution Medicines, Inc.$100M
- Kronos Bio, Inc.$105M
- Revolution Medicines, Inc.$56.4M
- Ideaya Biosciences, Inc.$94M
- Imaginab, Inc.$7.67M
- Cleave Biosciences, Inc.$26M
- Imaginab, Inc.$5.34M
- Blueprint Medicines Corp$50M
- Blueprint Medicines Corp$23.2M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2026 | 1 | 0 |
| 2025 | 1 | 0 |
| 2022 | 2 | — |
| 2020 | 3 | — |
| 2019 | 2 | — |
| 2018 | 2 | — |
| 2017 | 1 | — |
| 2016 | 2 | — |
| 2014 | 2 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Nextech Crossover I Scsp | 13 Apr 2023 | Open-ended | $208M |
Listed because a Nextech Crossover fund's filing names a director of each company. A name match is not a verified identity.